Levomilnacipran drug for functional rehabilitation after an acute neurological stroke
作者： Pierre Sokoloff
DOI:
关键词: Physical medicine and rehabilitation 、 Physical therapy 、 Drug 、 Functional recovery 、 Medicine 、 Functional rehabilitation 、 Stroke 、 Head trauma 、 Levomilnacipran
摘要: The present invention relates to the use of levomilnacipran as a drug in functional recovery after cerebrovascular accident or head trauma. pharmaceutical compositions containing are strictly those which levomilnacipran/dextromilnacipran mixture does not contain more than 5 wt % dextromilnacipran, so risk compromising due alpha-blocking property dextromilnacipran.
lens.org 参考文章(37)
Jay Kranzler, Michael Gendreau, Srinivas Rao, Methods for improving physical function in fibromyalgia ,(2008)
Dennis M Feeney, Ayshea M De Smet, Seema Rai, None, Noradrenergic modulation of hemiplegia: facilitation and maintenance of recovery. Restorative Neurology and Neuroscience. ,vol. 22, pp. 175- 190 ,(2004)
Sachiko Yatsugi, Masayasu Takahashi, Shinichi Yatsugi, Agent for promoting the recovery from dysfunction after the onset of central neurological disease ,(2005)
Jay D. Kranzler, Srinivas G. Rao, Michael R. Gendreau, Milnacipran for the treatment of cognitive dysfunction associated with fibromyalgia ,(2007)
Debra Lynn Stibick, Dennis Michael Feeney, None, Enduring vulnerability to transient reinstatement of hemiplegia by prazosin after traumatic brain injury. Journal of Neurotrauma. ,vol. 18, pp. 303- 312 ,(2001) , 10.1089/08977150151070955
Jay D. Kranzler, Srinivas G. Rao, Michael R. Gendreau, Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome ,(2007)
Jay D. Kranzler, Srinivas G. Rao, Prevention and treatment of functional somatic disorders, including stress-related disorders ,(2003)
Simone Zittel, Cornelius Weiller, Joachim Liepert, Reboxetine improves motor function in chronic stroke. A pilot study. Journal of Neurology. ,vol. 254, pp. 197- 201 ,(2007) , 10.1007/S00415-006-0326-5
Richard Grosse, Jean Deregnaucourt, Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament ,(2004)